Literature DB >> 21355238

[Chemical constituents from roots of Pueraria lobata].

Guohui Li1, Qingwen Zhang, Yitao Wang.   

Abstract

OBJECTIVE: To study the chemical constituents in the roots of Pueraria lobata.
METHOD: Various chromatographic methods were employed to separate of chemical constituents and the spectroscopic methods were used to elucidate the structure. RESULT: Twenty-two compounds were isolated and characterized as beta-sitosterol palmitate (1), beta-sitosterol (2), lupeol (3), lupeone (4) , puerarol (5), diisobutyl phthalate (6), bis(2-ethylhexyl) phthalate (7), sophoracoumestan A (8), coumestrol (9), allantion (10), dadzein (11), formononetin (12), 3'-methoxy daidzein (13), ononin (14), 3'-hydroxy dadzein (15), genistin (16), dadzin (17), 8-methoxy ononin (18), sissotorin (19), (-)-puerol B 2-O-glucopyranoside (20), (6S,9R)-roseoside (21) and sucrose (22), respectively.
CONCLUSION: Compounds 1, 5-8, 15, 18, 21 and 22 were isolated from P. lobata for the first time, and componds 1, 5-7, 15, 18, 21 and 22 were isolated from the genus Pueraria for the first time.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21355238

Source DB:  PubMed          Journal:  Zhongguo Zhong Yao Za Zhi        ISSN: 1001-5302


  3 in total

1.  Molecular cloning and characterization of an isoflavone 7-O-glucosyltransferase from Pueraria lobata.

Authors:  Jia Li; Zhaobo Li; Changfu Li; Junbo Gou; Yansheng Zhang
Journal:  Plant Cell Rep       Date:  2014-04-04       Impact factor: 4.570

2.  Potent suppression of HIV-1 cell attachment by Kudzu root extract.

Authors:  S Mediouni; J A Jablonski; S Tsuda; A Richard; C Kessing; M V Andrade; A Biswas; Y Even; T Tellinghuisen; H Choe; M Cameron; M Stevenson; S T Valente
Journal:  Retrovirology       Date:  2018-09-20       Impact factor: 4.602

3.  The cardioprotective effect of danshen and gegen decoction on rat hearts and cardiomyocytes with post-ischemia reperfusion injury.

Authors:  Fan Hu; Chi-Man Koon; Judy Yuet-Wa Chan; Kit-Man Lau; Kwok-Pui Fung
Journal:  BMC Complement Altern Med       Date:  2012-12-10       Impact factor: 3.659

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.